1. Automated insulin delivery systems improve glycemic control in type 1 diabetes.
2. AHCL and FCL show significant increases in time-in-range and reduction of hyperglycemia.
3. Further high-quality studies, especially for newer systems like FCL, are needed.
4. A clinically meaningful reduction in HbA1c was observed with AHCL.
5. AID systems consistently improved glycemic control.

Source: eClinicalMedicine